Arcus Biosciences Inc (NYSE:RCUS)
| 16.08 Delayed Data As of Dec 01 |  +1.02 / +6.77%Today’s Change | 12.95 Today|||52-Week Range 36.13 | -22.24% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $1.2B |
Company Description
Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.
Contact Information
Arcus Biosciences, Inc. 3928 Point Eden Way Hayward California 94545 |
Employees
Shareholders
| Individual stakeholders | 47.33% |
| Mutual fund holders | 42.24% |
| Other institutional | 24.01% |
Top Executives
| Terry J. Rosen | Chairman & Chief Executive Officer |
| Juan Carlos Jaen | President & Director |
| Jennifer A. Jarrett | Chief Operating Officer & Director |
| Robert C. Goeltz | Chief Financial Officer |
| Steve Young | Senior VP-Technology & Quantitative Biology |
